Join Clinical Trials in Hoover,Alabama

Browse Locations United States » Alabama » Hoover

Effect of Different Doses of SAR110894D on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012
A Study of Gantenerumab in Patients With Prodromal Alzheimer's Disease

Condition: Alzheimer Disease
Interventions: Drug: gantenerumab; Drug: gantenerumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012
Continued Safety Monitoring of Solanezumab in Alzheimer's Disease

Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients

Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012
A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients

Condition: Alzheimer Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg; Drug: Bapineuzumab 1.0 m/kg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012
Dominantly Inherited Alzheimer Network (DIAN)

Condition: Alzheimer's Disease
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute on Aging (NIA)
Recruiting - verified October 2011
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab; Drug: bapineuzumab; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012